NewEdge Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30
| Closed | -$1.34K | – | 3842 |
|
|
2024
Q2 | $1.34K | Buy |
+30
| New | +$1.34K | ﹤0.01% | 3409 |
|
|
2023
Q2 | – | Sell |
-60
| Closed | -$964 | – | 3513 |
|
|
2023
Q1 | $964 | Hold |
60
| – | – | ﹤0.01% | 3159 |
|
|
2022
Q4 | $1 | Buy |
+60
| New | +$1 | ﹤0.01% | 3992 |
|